These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 24307138)

  • 1. Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.
    Matilla-Dueñas A; Ashizawa T; Brice A; Magri S; McFarland KN; Pandolfo M; Pulst SM; Riess O; Rubinsztein DC; Schmidt J; Schmidt T; Scoles DR; Stevanin G; Taroni F; Underwood BR; Sánchez I
    Cerebellum; 2014 Apr; 13(2):269-302. PubMed ID: 24307138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spinocerebellar ataxias.
    Paulson HL
    J Neuroophthalmol; 2009 Sep; 29(3):227-37. PubMed ID: 19726947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
    Matilla-Dueñas A; Sánchez I; Corral-Juan M; Dávalos A; Alvarez R; Latorre P
    Cerebellum; 2010 Jun; 9(2):148-66. PubMed ID: 19890685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of spinocerebellar ataxias.
    Dueñas AM; Goold R; Giunti P
    Brain; 2006 Jun; 129(Pt 6):1357-70. PubMed ID: 16613893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal-dominant cerebellar ataxias.
    Mundwiler A; Shakkottai VG
    Handb Clin Neurol; 2018; 147():173-185. PubMed ID: 29325610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
    Kasumu A; Bezprozvanny I
    Cerebellum; 2012 Sep; 11(3):630-9. PubMed ID: 20480274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinocerebellar ataxia: an update.
    Sullivan R; Yau WY; O'Connor E; Houlden H
    J Neurol; 2019 Feb; 266(2):533-544. PubMed ID: 30284037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ever expanding spinocerebellar ataxias. Editorial.
    Matilla-Dueñas A
    Cerebellum; 2012 Dec; 11(4):821-7. PubMed ID: 22447528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.
    Cendelin J; Cvetanovic M; Gandelman M; Hirai H; Orr HT; Pulst SM; Strupp M; Tichanek F; Tuma J; Manto M
    Cerebellum; 2022 Jun; 21(3):452-481. PubMed ID: 34378174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias.
    Szpisjak L; Zadori D; Klivenyi P; Vecsei L
    CNS Neurol Disord Drug Targets; 2019; 18(4):279-293. PubMed ID: 30864514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain pathology of spinocerebellar ataxias.
    Seidel K; Siswanto S; Brunt ER; den Dunnen W; Korf HW; Rüb U
    Acta Neuropathol; 2012 Jul; 124(1):1-21. PubMed ID: 22684686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machado-Joseph disease and other rare spinocerebellar ataxias.
    Matilla-Dueñas A
    Adv Exp Med Biol; 2012; 724():172-88. PubMed ID: 22411243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.
    Underwood BR; Rubinsztein DC
    Cerebellum; 2008; 7(2):215-21. PubMed ID: 18418676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson HL
    Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
    Buijsen RAM; Toonen LJA; Gardiner SL; van Roon-Mom WMC
    Neurotherapeutics; 2019 Apr; 16(2):263-286. PubMed ID: 30607747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinocerebellar ataxias: an update.
    Soong BW; Paulson HL
    Curr Opin Neurol; 2007 Aug; 20(4):438-46. PubMed ID: 17620880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic mechanisms underlying spinocerebellar ataxia type 1.
    Tejwani L; Lim J
    Cell Mol Life Sci; 2020 Oct; 77(20):4015-4029. PubMed ID: 32306062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do so many genetic insults lead to Purkinje Cell degeneration and spinocerebellar ataxia?
    Huang M; Verbeek DS
    Neurosci Lett; 2019 Jan; 688():49-57. PubMed ID: 29421540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging pathogenic pathways in the spinocerebellar ataxias.
    Carlson KM; Andresen JM; Orr HT
    Curr Opin Genet Dev; 2009 Jun; 19(3):247-53. PubMed ID: 19345087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinocerebellar ataxia.
    Klockgether T; Mariotti C; Paulson HL
    Nat Rev Dis Primers; 2019 Apr; 5(1):24. PubMed ID: 30975995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.